Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 2/20 | 0.66 |
| ▸ | TLR2 | O60603 | 2/20 | 0.66 |
| ▸ | FBP1 | P09467 | 3/20 | 0.59 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.56 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | EGFR | P00533 | 3/20 | 0.51 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.51 |
| ▸ | AHR | P35869 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13515394 | 1.00 | TLR4 (0.66) | TLR4TLR2FBP1NCOA1NCOA3 | |
| SCHEMBL5688276 | 1.00 | TLR4 (0.66) | TLR4TLR2FBP1NCOA1NCOA3 | |
| SCHEMBL509742 | 0.95 | TLR4 (0.71) | TLR4TLR2FBP1NCOA1NCOA3 | |
| SCHEMBL509743 | 0.95 | TLR4 (0.71) | TLR4TLR2FBP1NCOA1NCOA3 | |
| SCHEMBL17070027 | 0.92 | FBP1 (0.64) | TLR4TLR2FBP1ALDH1A1LMNA | |
| SCHEMBL10485379 | 0.85 | PTGS2 (0.71) | NCOA1NCOA3ALDH1A1LMNAMAPT | |
| SCHEMBL16632344 | 0.84 | PTGS2 (0.69) | TLR4TLR2FBP1ALDH1A1LMNA | |
| SCHEMBL16632342 | 0.84 | PTGS2 (0.69) | TLR4TLR2FBP1ALDH1A1LMNA | |
| SCHEMBL23998046 | 0.84 | AHR (0.67) | AHRNR5A1TP53TSHR | |
| SCHEMBL2042216 | 0.84 | AHR (0.67) | AHRNR5A1TP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1265483-B1 | USE OF PHENYLETHYLAMINE DERIVATIVES FOR THE ANITMICROBIAL TREATMENT OF SURFACES | CIBA SC HOLDING AG (CH) | 2006-03-29 | — | — | EP | disclosed |
| US-6846492-B2 | Use of phenylethylamine derivatives for the antimicrobial treatment of surfaces | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2005-01-25 | — | — | US | disclosed |
| US-20030207884-A1 | Use of phenylethylamine derivatives for the antimicrobial treatment of surfaces | CIBA SPECIALTY CHEMICALS CORP. | 2003-11-06 | — | — | US | disclosed |
| EP-1265483-A2 | USE OF PHENYLETHYLAMINE DERIVATIVES FOR THE ANITMICROBIAL TREATMENT OF SURFACES | Ciba SC Holding AG (CH) | 2002-12-18 | — | — | EP | disclosed |
| WO-2001062082-A2 | USE OF PHENYLETHYLAMINE DERIVATIVES FOR THE ANITMICROBIAL TREATMENT OF SURFACES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2001-08-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030207884-A1 | Use of phenylethylamine derivatives for the antimicrobial treatment of surfaces | CLTC, TUBA3C, AOC1 | TLR4 298/4885TLR2 39/4885FBP1 3978/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.